Evidence map›Paper›PMID 26993811›Full record

ArticleNeuroradiology2016

MRI and (1)H-MRS in adenosine kinase deficiency.

C Staufner, H J Blom, C Dionisi-Vici, P Freisinger, N Makhseed, D Ballhausen, S Kölker, G F Hoffmann, I Harting

Abstract read
PubMed Publisher
In one paragraph

Article in Neuroradiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

C StaufnerDepartment of General Pediatrics, Division of Neuropediatrics and Pediatric Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany.
H J BlomCenter for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg, Germany.
C Dionisi-ViciDivision of Metabolism, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
P FreisingerChildren's Hospital Reutlingen, Reutlingen, Germany.
N MakhseedDepartment of Pediatrics, Jahra Hospital, Jahra, Kuwait.
D BallhausenCenter for Molecular Diseases, CHUV Lausanne, Lausanne, Switzerland.
S KölkerDepartment of General Pediatrics, Division of Neuropediatrics and Pediatric Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany.
G F HoffmannDepartment of General Pediatrics, Division of Neuropediatrics and Pediatric Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany.
I HartingDepartment of Neuroradiology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. inga.harting@med.uni-heidelberg.de.ORCID http://orcid.org/0000-0002-5734-8548
Heidelberg University · DEBambino Gesù Children's Hospital · ITJahra Hospital · KWReutlingen University · DEUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdenosine kinase deficiency (ADK deficiency) is a recently described disorder of methionine and adenosine metabolism resulting in a neurological phenotype with developmental delay, muscular hypotonia, and epilepsy as well as variable systemic manifestations. The underlying neuropathology is poorly understood. We have investigated MRI and (1)H-MRS changes in ADK deficiency in order to better understand the in vivo neuropathologic changes of ADK deficiency.

methodsSystematic evaluation of 21 MRIs from eight patients (age range 9 days-14.6 years, mean 3.9 years, median 2.7 years) including diffusion-weighted imaging in six and (1)H-MRS in five patients.

resultsBrain maturation was delayed in the neonatal period and in infancy (6/6), but ultimately complete. White matter changes occurring in five of eight patients were discrete, periventricular, and unspecific (4/5), or diffuse with sparing of optic radiation, corona radiata, and pyramidal tracts (1/5). Choline was low in white matter spectra (3/3), while there was no indication of low creatine in white matter or basal ganglia (5/5), and diffusion was variably decreased or increased. Central tegmental tract hyperintensity was a common finding (6/8), as was supratentorial atrophy (6/8).

conclusionsMRI changes in ADK deficiency consist of delayed but ultimately completed brain maturation with later onset of mostly unspecific white matter changes and potentially transient central tegmental tract hyperintensity. Immaturity on neonatal MRI is consistent with prenatal onset of disease and reduced choline with lower membrane turnover resulting in delayed myelination and deficient myelin maintenance.

Indexed as

Adenosine KinaseAdolescentBrainBrain Diseases, MetabolicChildChild, PreschoolFemaleHumansInfantInfant, NewbornMagnetic Resonance ImagingMaleMolecular ImagingProton Magnetic Resonance SpectroscopyReproducibility of ResultsSensitivity and SpecificityAdenosine KinaseAdenosine kinase deficiencyBrain maturationDiffusion-weighted imagingMagnetic resonance spectroscopyNeurometabolic disorders

Identifiers

PMID26993811
OpenAlexW2297478245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.